These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32487452)

  • 1. TFDA takes actions to help mitigate supply disruptions or shortages of drug.
    Liu SC; Huang MC; Horng SS
    J Formos Med Assoc; 2020 Oct; 119(10):1459-1460. PubMed ID: 32487452
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future.
    Kuo S; Ou HT; Wang CJ
    J Am Pharm Assoc (2003); 2021; 61(1):e12-e15. PubMed ID: 32919923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey.
    Zaidi STR; Hasan SS
    Res Social Adm Pharm; 2021 Jan; 17(1):1832-1837. PubMed ID: 33317761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug shortages: causes and cautions.
    Mullins TD; Cook AM
    Orthopedics; 2011 Sep; 34(9):712-4. PubMed ID: 21899237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintaining drug supply to Greece in an uncertain future.
    Burki TK
    Lancet Oncol; 2015 Aug; 16(8):e382. PubMed ID: 26166437
    [No Abstract]   [Full Text] [Related]  

  • 6. Looking for the treatment for drug shortages: not a simple prescription.
    Berry AJ
    Mayo Clin Proc; 2014 Mar; 89(3):281-3. PubMed ID: 24582186
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA, US hospital and pharmacy groups report drug shortages a growing problem.
    Mitka M
    JAMA; 2011 Sep; 306(10):1069-70. PubMed ID: 21917568
    [No Abstract]   [Full Text] [Related]  

  • 8. National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages.
    Piatek OI; Ning JC; Touchette DR
    Am J Health Syst Pharm; 2020 Oct; 77(21):1778-1785. PubMed ID: 32716030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conquering Fear During Social-Distancing or Self-Quarantine: Even Fearing the Disappearance of Popcorn.
    Wright LM
    J Fam Nurs; 2020 Aug; 26(3):187-189. PubMed ID: 32808590
    [No Abstract]   [Full Text] [Related]  

  • 10. Pediatric drug shortages: a deplorable fact and a political problem.
    Shader RI
    Clin Ther; 2014 Feb; 36(2):151-2. PubMed ID: 24529285
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective actions against the second wave of COVID-19: the front-line experience from China.
    Xu JW; Liu JQ; Ke L; Wang JN; Sun CY; Gao L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11995-11997. PubMed ID: 33336783
    [No Abstract]   [Full Text] [Related]  

  • 12. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
    Tetteh E
    Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
    [No Abstract]   [Full Text] [Related]  

  • 13. Strict Containment Strategy and Rigid Social Distancing Successfully Contained COVID-19 in the Military in South Korea.
    Oh HS; Woong S
    Mil Med; 2020 Dec; 185(11-12):476-479. PubMed ID: 32766677
    [No Abstract]   [Full Text] [Related]  

  • 14. Medication Shortages During the COVID-19 Crisis: What We Must Do.
    Choo EK; Rajkumar SV
    Mayo Clin Proc; 2020 Jun; 95(6):1112-1115. PubMed ID: 32312491
    [No Abstract]   [Full Text] [Related]  

  • 15. WTO TRIPS and its effect on the supply and development of medicines in China.
    Tanner JA
    Hong Kong Med J; 2006 Feb; 12(1):84-6. PubMed ID: 16495599
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential changes to the hikikimori phenomenon in the wake of the Covid-19 pandemic.
    Wong PWC
    Asian J Psychiatr; 2020 Dec; 54():102288. PubMed ID: 32682300
    [No Abstract]   [Full Text] [Related]  

  • 17. A dynamical framework for modeling fear of infection and frustration with social distancing in COVID-19 spread.
    Johnston MD; Pell B
    Math Biosci Eng; 2020 Nov; 17(6):7892-7915. PubMed ID: 33378925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social distancing measures in the fight against COVID-19 in Brazil: description and epidemiological analysis by state.
    Silva LLSD; Lima AFR; Polli DA; Razia PFS; Pavão LFA; Cavalcanti MAFH; Toscano CM
    Cad Saude Publica; 2020; 36(9):e00185020. PubMed ID: 32965378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It Takes a Village…: Contending With Drug Shortages During Disasters.
    Burry LD; Barletta JF; Williamson D; Kanji S; Maves RC; Dichter J; Christian MD; Geiling J; Erstad BL
    Chest; 2020 Dec; 158(6):2414-2424. PubMed ID: 32805237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Victoria's Stage 3 lockdown on COVID-19 case numbers.
    Saul A; Scott N; Crabb BS; Majumdar SS; Coghlan B; Hellard ME
    Med J Aust; 2020 Dec; 213(11):494-496.e1. PubMed ID: 33230817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.